Average Co-Inventor Count = 1.81
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Sepracor, Inc. (10 from 322 patents)
2. Bridge Pharma Inc. (2 from 34 patents)
3. Sunovion Pharmaceuticals Inc. (1 from 130 patents)
13 patents:
1. 8062627 - Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
2. 7718674 - Methods of relieving neuropathic pain with the S-isomer of 2-{2[N-(2-indanyl)-N-phenylamino]ethyl}piperidine
3. 7368120 - Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
4. 6866839 - Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
5. 6589508 - Methods and compositions for treating pulmonary disorders using optically pure (R,R) formoterol
6. 6310103 - S(−)-tolterodine in the treatment of urinary and gastrointestinal disorders
7. 6299863 - Aerosol formulations containing micronized optically pure (R,R) formoterol for bronchodilating therapy
8. 6068833 - Methods and compositions for treating pulmonary disorders using
9. 5807541 - NSAID/fluoride periodontal compositions and methods
10. 5795564 - Methods and compositions for treating pulmonary disorders using
11. 5736577 - Methods and compositions for treating urinary incontinence using
12. 5677346 - Treating urinary incontinence using (S)-desethyloxybutynin
13. 5532278 - Methods and compositions for treating urinary incontinence using